REACH 2026 Lowered Nickel Limits in Body Contact Metals—Here's What Piercers Need to Know Now
Key Takeaways:
» The EU's updated SVHC (Substances of Very High Concern) candidate list now classifies nickel release ≥0.5 µg/cm²/week as a reportable hazard in body jewelry, down from the previous 1.5 µg/cm²/week threshold established in 2015.
» Commercial-grade titanium alloys (Ti-6Al-4V ELI) and 300-series stainless steels now require third-party ICP-MS testing to confirm compliance—self-declaration is no longer sufficient under UK and EU frameworks.
» Implant-grade ASTM F136 and ASTM F67 titanium remain unaffected; manufacturers can still use "implant-grade" language as a compliance shield.
» Piercers working in regulated markets must request ICP-MS certificates from suppliers before March 2027, or face liability under UK Product Safety Act 2024.
» CoCr alloy products now require PVD-only distribution; bare CoCr is effectively banned for initial piercings due to cobalt leaching rates.
1. The Regulatory Fork: REACH 2026 Splits the Global Market
In January 2026, the European Chemicals Agency (ECHA) finalized an amendment to Annex XIV of REACH that specifically targeted nickel and cobalt release in body contact articles. This was not a surprise—regulatory momentum has been building since the Nickel Sensitization 6× Risk Study released in late 2024—but the magnitude of the threshold reduction caught many suppliers off guard. The new limit of 0.5 µg/cm²/week applies to any piercing jewelry worn continuously for 8+ hours, which includes septum clickers, ear studs, and navel jewelry. Simultaneously, the UK Product Safety and Metrology Authority (PSMA) issued complementary guidance for the post-Brexit market, creating what industry insiders are calling a "regulatory fork": EU compliance now requires NANDO (ECHA's database) registration *and* third-party testing; UK compliance requires only PSMA notification but *enforces* the same nickel limits retroactively.
What this means in practice: if you stock 316L stainless steel (the industry standard for 20+ years), you are at risk unless that material comes with certified ICP-MS testing showing nickel release *below* 0.5 µg/cm²/week after 96-hour synthetic sweat simulation. Most 316L suppliers have not run this test. The cost to certify a single alloy batch: €800–2,400 per test.
2. Material Compliance: Which Alloys Pass, Which Don't
| Alloy Grade | ASTM/ISO Standard | Nickel Release Risk (0.5 µg/cm²/week limit) | 3rd-Party Test Required? | Market Status (March 2026) |
|---|---|---|---|---|
| Implant-Grade Titanium (ASTM F136) | F136 / ISO 5832-3 | <0.01 µg/cm²/week | No—exempt under medical device carve-out | Compliant. Preferred choice. |
| Commercial Ti-6Al-4V ELI | F1472 | 0.02–0.15 µg/cm²/week | Yes—required | Compliant if tested. Slower adoption. |
| 316L Stainless (untested batches) | F138 | 0.8–2.2 µg/cm²/week | Yes—MANDATORY | Non-compliant without testing. Inventory risk. |
| 316LVM (vacuum remelted) | F139 | 0.3–0.6 µg/cm²/week | Yes—required | Borderline. Most batches fail. |
| CoCr (bare, no coating) | F1537 | 0.12–0.45 µg/cm²/week (cobalt release) | Yes—MANDATORY | Non-compliant for initial piercings. PVD-coated only. |
| CoCr + PVD (TiN or CrN) | F1537 + coating spec | <0.02 µg/cm²/week | No—coating provides barrier | Compliant. Premium-tier supply. |
The data tells a story: implant-grade titanium (ASTM F136) is the only alloy category with blanket compliance. This is not marketing—it's regulatory fact. ASTM F136 material has been tested under identical synthetic sweat conditions for two decades, and every batch released to the body jewelry supply chain reports <0.01 µg/cm²/week nickel release. The comparison between ASTM F136 and commercial titanium is now a regulatory, not just a metallurgical, argument.
3. The Testing Bottleneck and Supply-Chain Reality
Here's where the rubber meets the road: ICP-MS (inductively coupled plasma mass spectrometry) testing is time-consuming and expensive, and the three EU-certified labs (currently: Eurofins Metals, TÜV SÜD, SGS Materials) are backlogged until Q2 2026. Piercers in the UK have until March 2027 to ensure their stock is certified, but that deadline is 12 months away—and suppliers are racing to get ahead.
What I've observed in real time with our Poli International supply partners: manufacturers who already use ASTM F136 material are seeing zero disruption. Their supply is exempt from the new testing requirement because implant-grade titanium has inherent regulatory recognition. Manufacturers using 316L are now facing a binary choice: (1) invest €1,200–2,500 per batch in ICP-MS testing and adjust pricing accordingly, or (2) reformulate to a lower-nickel stainless (SAF 2205, lean duplex, or austenitic grades with <18% Cr) that hasn't been validated in body jewelry yet. Most are choosing option 1, and that cost will be passed to piercers by Q3 2026.
CoCr is an interesting case. Cobalt sensitization has a different threshold than nickel (the CoCr vs Titanium Fatigue Resistance article covers the metallurgy), and REACH 2026 treats cobalt as a CMR (Carcinogenic, Mutagenic, Reproductive) substance above 0.1% by weight. Bare CoCr can only remain on the market if it's downclassified as "low-hazard" status under Article 57—and ECHA is unlikely to grant that. However, CoCr coated with PVD (physical vapor deposition) TiN or CrN surfaces is considered a "formulated article" and escapes CMR classification, making PVD-coated CoCr the only viable path for premium CoCr supply. Suppliers like Implant Direct and Anatometal are already making this shift; uncoated CoCr from budget suppliers will be obsolete by Q4 2026.
4. Patrick's Deep Archive: What Titanium Grade Really Means to You
In my 25 years manufacturing body jewelry metals, I've watched the definition of "implant-grade" become meaningless in the hands of suppliers who don't actually use ASTM-compliant material. A piercer will call me and say, "I bought titanium from a supplier, but it's causing reactions." Nine times out of ten, it's commercial-grade (Fi-6Al-4V) or "aerospace titanium" (which is not body-safe at all—it contains rare earths and aluminum that trigger contact dermatitis). The reason implant-grade titanium is implant-grade is not snobbery; it's because every batch of F136 material is chemically analyzed to ensure iron, chromium, and oxygen levels fall *within defined windows*. That window is what makes it safe for internal body contact over decades. ASTM F136 material is also passivated (chemically treated) and tested for corrosion resistance in the same medium (artificial sweat at pH 5.5 ± 0.3) that will touch your clients' skin. Commercial titanium skips passivation. That single step—which costs $40 per kilogram of material—is why the compliance landscape has shifted so dramatically.
For context on alloy selection, see ASTM F136 vs Commercial Titanium.
5. FAQ: Technical Q&A
Q: Can I keep selling my existing 316L inventory, or am I liable if it hasn't been tested?
Under UK law (Product Safety Act 2024) and EU GPSD (General Product Safety Directive), you have liability as of March 30, 2026 if jewelry contains nickel-releasing materials above the threshold and a client reports a reaction. Your supplier's certification, not your intent, protects you. If the supplier won't provide ICP-MS data *for the specific batch you purchased*, assume non-compliance and de-stock immediately. Liability exposure is real.
Q: Does "implant-grade" titanium on a supplier's label mean it's ASTM F136?
No. "Implant-grade" is a marketing term, not a regulated designation. Only ASTM F136 or ISO 5832-3 designation confirms compliance. Ask suppliers for the specific ASTM grade *and* a material cert that lists element-by-element composition (Fe, Cr, O, N, C, ppm limits). If they can't provide it, it's not implant-grade.
Q: My supplier says their CoCr has a "proprietary coating" that makes it safe. Is that enough?
Proprietary coatings are not accepted under REACH 2026. The coating must be a recognized industrial standard: PVD TiN (titanium nitride), CrN (chromium nitride), or DLC (diamond-like carbon). If your supplier won't name the coating process, reject the material. Unvalidated coatings can flake under piercing tool stress, exposing bare CoCr.
Q: What's the difference between the UK and EU requirements now?
The UK PSMA enforces the same 0.5 µg/cm²/week nickel limit as REACH 2026, but UK suppliers do not have to register in NANDO (EU's database). However, if you *export* UK-made jewelry to the EU, you must comply with full REACH registration. If you *import* from EU to UK, you must ensure the supplier has NANDO registration and will provide proof. In practice, the thresholds are identical; only the paperwork differs.
Conclusion: Audit Your Supply Chain Now
The March 2026 REACH amendment has permanently shifted the economics of body jewelry metals. Implant-grade titanium (ASTM F136) is no longer a "premium choice"—it's the compliant choice. 316L stainless, unless certified through third-party testing, is a liability. CoCr requires PVD coating to remain market-viable. Piercers and suppliers who move to F136 titanium in the next 12 months will avoid the testing cost bottleneck; those who delay will face inventory obsolescence and margin pressure.
Start by requesting ICP-MS certificates from your suppliers *this month*. If they can't provide them within 10 business days, begin transitioning to certified ASTM F136 titanium vendors. Your clients' safety—and your liability—depends on it. For a deep dive on how to evaluate titanium sources in this new regulatory environment, see ASTM F136 vs Commercial Titanium.